-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on RXO, Raises Price Target to $24

Benzinga·05/08/2026 20:03:34
Listen to the news
Citigroup analyst Ariel Rosa maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $17 to $24.